GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network

GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
MELBOURNE, Australia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce a partnership with the Gold Coast Private Hospital (GCPH), a member of Healthscope, to establish a Precision Medicine Clinic at the hospital.
Highlights:
Partnership will be initiated with a 50-patient pilot study to establish workflow and patient reporting.
Pilot study will utilise geneType Multi-risk test combined with Pharmacogenomics (PGx) tests, providing a comprehensive wellness profile for GCPH patients.
Patient recruitment to commence immediately.
Positive outcomes could enable the rollout of additional Precision Medicine Clinics throughout the Healthscope network.
Gold Coast Private Hospital by Healthscope is a 336 bed, 22 theatre hospital and home to leading doctors and surgeons from around the world.
Healthscope is Australia's only national private hospital operation and healthcare provider with a network of 42 hospitals that service every state and territory with 19,000 employees.

According to the US Food and Drug Administration (FDA), Precision Medicine, also known as "personalised medicine" is an innovative approach to tailoring disease prevention and treatment that takes into account differences in people's genes, environments, and lifestyles. The goal of precision medicine is to target the right treatments to the right patients at the right time. Utilising GTG’s geneType Multi-test and PGx tests will be an important step in improving health outcomes for GCPH’s patients.
Research Manager for the Gold Coast private hospital, Michelle Ferrari Cestari, commented, “We have a clear vision for a Precision Medicine Clinic that focuses on preventative care, wellness and creating proactive patient pathways that lead to early detection, and better treatment of the common diseases.”

-END-
Enquiries
Investor Relations
Adrian Mulcahy
Automic Markets
M: +61 438 630 411
E: adrian.mulcahy@automicgroup.com.au
Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company. A global leader in genomics-based tests in health, wellness and serious disease through its geneType and EasyDNA brands. GTG offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The company has a proprietary risk stratification platform that has been developed over the past decade and integrates clinical and genetic risk to deliver actionable outcomes to physicians and individuals. Leading the world in risk prediction in oncology, cardiovascular and metabolic diseases, Genetic Technologies continues to develop risk assessment products. For more information, please visit www.genetype.com
Gold Coast Private Hospital by Healthscope is a 336 bed and 22 theatre hospital is home to leading doctors and surgeons. The focus is on the patient with and expert team of surgeons, specialist doctors, dedicated nurses and other supporting health professionals ensuring holistic health care experience is the best it can be.
Offering the latest technology, and truly impressive state-of-the-art facilities, they attract leading doctors and surgeons from across the world. This, in turn, has meant that we are the Gold Coast hospital of choice for GPs, consultants and, of course, patients who quite rightly place a premium on their health and wellbeing https://goldcoastprivatehospital.com.au
Healthscope is Australia's only national private hospital operation and healthcare provider with a network of 42 hospitals that service every state and territory. With over 19,000 people and provide work for nearly as many accredited medical practitioners. Our people are known for achieving exceptional clinical outcomes, transparent public reporting and positive patient feedback that leads the industry. No matter the role, every day the people make a difference to the lives of patients, their families and carers, and it is a privilege to be part of their care. https://healthscope.com.au/
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/a4b69bd4-9db5-48df-8571-1c750c1c10c6
https://www.globenewswire.com/NewsRoom/AttachmentNg/49b7d9ad-c0a0-48c8-a599-e7fbec9517ce


更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。